Logo image of GPUS

HYPERSCALE DATA INC (GPUS) Stock Fundamental Analysis

USA - NYSEARCA:GPUS - US09175M8047 - Common Stock

0.3839 USD
0 (-0.29%)
Last: 10/23/2025, 8:06:23 PM
0.3864 USD
+0 (+0.65%)
After Hours: 10/23/2025, 8:06:23 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GPUS. GPUS was compared to 7 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of GPUS have multiple concerns. GPUS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GPUS had negative earnings in the past year.
GPUS had a negative operating cash flow in the past year.
GPUS had negative earnings in each of the past 5 years.
GPUS had negative operating cash flow in 4 of the past 5 years.
GPUS Yearly Net Income VS EBIT VS OCF VS FCFGPUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of GPUS (-26.29%) is worse than 85.71% of its industry peers.
The Return On Equity of GPUS (-1018.69%) is worse than 71.43% of its industry peers.
Industry RankSector Rank
ROA -26.29%
ROE -1018.69%
ROIC N/A
ROA(3y)-45.99%
ROA(5y)-36.36%
ROE(3y)-439.95%
ROE(5y)-278.29%
ROIC(3y)N/A
ROIC(5y)N/A
GPUS Yearly ROA, ROE, ROICGPUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

With a decent Gross Margin value of 20.94%, GPUS is doing good in the industry, outperforming 71.43% of the companies in the same industry.
GPUS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GPUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.3%
GM growth 5Y10.66%
GPUS Yearly Profit, Operating, Gross MarginsGPUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

GPUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
GPUS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GPUS has been increased compared to 5 years ago.
Compared to 1 year ago, GPUS has a worse debt to assets ratio.
GPUS Yearly Shares OutstandingGPUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
GPUS Yearly Total Debt VS Total AssetsGPUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -5.17, we must say that GPUS is in the distress zone and has some risk of bankruptcy.
GPUS's Altman-Z score of -5.17 is fine compared to the rest of the industry. GPUS outperforms 71.43% of its industry peers.
GPUS has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GPUS (0.15) is better than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -5.17
ROIC/WACCN/A
WACC9.38%
GPUS Yearly LT Debt VS Equity VS FCFGPUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 0.31 indicates that GPUS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.31, GPUS is doing worse than 85.71% of the companies in the same industry.
A Quick Ratio of 0.30 indicates that GPUS may have some problems paying its short term obligations.
GPUS has a Quick ratio of 0.30. This is amonst the worse of the industry: GPUS underperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.3
GPUS Yearly Current Assets VS Current LiabilitesGPUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.03% over the past year.
GPUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.76%.
Measured over the past years, GPUS shows a very strong growth in Revenue. The Revenue has been growing by 36.68% on average per year.
EPS 1Y (TTM)83.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.96%
Revenue 1Y (TTM)-35.76%
Revenue growth 3Y26.73%
Revenue growth 5Y36.68%
Sales Q2Q%-8.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GPUS Yearly Revenue VS EstimatesGPUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GPUS Yearly EPS VS EstimatesGPUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 -5K -10K -15K

0

4. Valuation

4.1 Price/Earnings Ratio

GPUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GPUS Price Earnings VS Forward Price EarningsGPUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GPUS Per share dataGPUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GPUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HYPERSCALE DATA INC

NYSEARCA:GPUS (10/23/2025, 8:06:23 PM)

After market: 0.3864 +0 (+0.65%)

0.3839

0 (-0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-17 2025-11-17
Inst Owners0.28%
Inst Owner Change1.45%
Ins Owners0.04%
Ins Owner Change97.4%
Market Cap74.45M
Revenue(TTM)101.38M
Net Income(TTM)-56140000
Analysts82.86
Price TargetN/A
Short Float %4.12%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.98
Dividend Growth(5Y)N/A
DP-12.24%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 13.51
P/tB 19.29
EV/EBITDA N/A
EPS(TTM)-30.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.52
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.29%
ROE -1018.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.94%
FCFM N/A
ROA(3y)-45.99%
ROA(5y)-36.36%
ROE(3y)-439.95%
ROE(5y)-278.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.3%
GM growth 5Y10.66%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.89%
Cap/Sales 4.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.3
Altman-Z -5.17
F-Score5
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)200.34%
Cap/Depr(5y)1362.93%
Cap/Sales(3y)34.08%
Cap/Sales(5y)78.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.76%
Revenue growth 3Y26.73%
Revenue growth 5Y36.68%
Sales Q2Q%-8.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.37%
OCF growth 3YN/A
OCF growth 5YN/A